Interventional Cardiologists successfully complete Adventist Health Glendale’s first TriClip procedures

Dr. Harry Balian, Medical Director of Adventist Health Glendale’s Cardiovascular Services, and Dr. Amir Solhpour, Medical Director of the hospital’s Structural Heart Program, performed two successful TriClip procedures in May 2024. Adventist Health Glendale is one of only four Southland hospitals to complete TriClip procedures since the device was approved by the Food and Drug Administration in April 2024 to treat tricuspid regurgitation.

By introducing TriClip capability, Adventist Health Glendale bolstered its cardiovascular program, which already features a wide range of diagnostic and therapeutic services, including structural heart procedures like TAVR, Watchman and MitraClip. The inaugural TriClip procedures came precisely one week after Dr. Balian completed the hospital’s 200th MitraClip case, a minimally invasive procedure to implant a clip in the mitral valve between the heart’s left atrium and left ventricle.

“Tricuspid regurgitation is a life-threatening condition that, until now, would have required complex, open-heart surgery. The TripClip technology offers a minimally invasive treatment option for patients needing tricuspid valve repair without the inherent risks of an open-heart procedure,” explained Dr. Sohlpour. “We’re extremely proud to be among the first in California to offer this innovative treatment option for our patients, particularly our older patients at risk of heart failure.”

The surgeons were assisted by a team of cardiovascular specialty technicians and nurses in Adventist Health Glendale’s award-winning cardiac catheterization (cath) laboratory, acclaimed by Healthgrades as one of America’s 50 Best Hospitals for Cardiac Surgery.

Updated September 16, 2024